Cleared Abbreviated

K022906 - RESQPOD CIRCULATORY ENHANCER

K022906 is an FDA 510(k) clearance for RESQPOD CIRCULATORY ENHANCER, manufactured by Cprx, LLC. The device is a Class 2 Anesthesiology device with product code BWF cleared through the Abbreviated 510(k) pathway after a 281-day FDA review.

K022906 · Cprx, LLC · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2003
Decision
281d
Days
Class 2
Risk

K022906 is an FDA 510(k) clearance for the RESQPOD CIRCULATORY ENHANCER. Classified as Spirometer, Therapeutic (incentive) (product code BWF), Class II - Special Controls.

Submitted by Cprx, LLC (Eden Prairie, US). The FDA issued a Cleared decision on June 11, 2003 after a review of 281 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5690 - the FDA anesthesiology and respiratory device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Cprx, LLC devices

FDA 510(k) Submission Details - K022906

510(k) Number K022906 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 03, 2002
Decision Date June 11, 2003
Days to Decision 281 days
Submission Type Abbreviated
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
141d slower than avg
Panel avg: 140d · This submission: 281d
Pathway characteristics
Standards-based clearance path.

BWF Device Classification - Class 2, Special Controls

Product Code BWF Spirometer, Therapeutic (incentive)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BWF Spirometer, Therapeutic (incentive)

All 63
Devices cleared under the same product code (BWF) and FDA review panel - the closest regulatory comparables to K022906.
VOLUMETRIC INCENTIVE SPIROMETER
K141355 · Besmed Health Business Corporation · Sep 2014
TRIBALL INCENTIVE SPIROMETER
K133873 · Besmed Health Business Corp · Apr 2014
AEROBIKA POSITIVE EXPIRATORY PRESSURE DEVICE
K123400 · Trudell Medical Intl. · May 2013
TRI-BALL
K994074 · Leventon, S.A. · Jun 2000
INCENTIVE SPIROMETER
K000314 · Engineered Medical Systems · Apr 2000
FROLOV'S RESPIRATION TRAINING DEVICE, FRTD-01
K992256 · Intercontinental New Technologies, Inc. · Jan 2000